Keyphrases
COVID-19
100%
Indonesia
56%
Institutional Diagnostics
50%
Radiation Workers
50%
Radiation-induced Cataract
50%
Diagnostic Reference Levels
50%
Tocilizumab
50%
Cytokine Storm Syndrome
50%
Multifocal Recurrence
50%
Long Follow-up
50%
Medulloblastoma
50%
Cataract
50%
Radiation Protection
50%
Interventional Cardiology
50%
Protection Equipment
50%
Diagnostic Approach
50%
Ionizing Radiation Effects
50%
Dacryoscintigraphy
50%
Dacryocystography
50%
Brixia Score
50%
Thyroid Nodule
50%
Viral Pneumonia
50%
COVID-19 Severity
50%
Image Features
50%
Feature-based
50%
Artificial Intelligence
50%
Congenital Nasolacrimal Duct Obstruction (CNLDO)
50%
Degree of Agreement
50%
Diagnostic Test Accuracy
50%
Imaging Diagnostics
50%
Chest X-ray Images
50%
Detection Method
50%
Scanned Image
50%
Examination Results
50%
Computed Tomography
50%
Lung Field
50%
Discrimination Power
50%
Cumulative Radiation Dose
37%
Protective Eyewear
37%
Working Period
37%
Radiation Dose
37%
Confidence Level
37%
Cataract Risk Factors
25%
Exposure Radiation
25%
Confidence Interval
25%
Supratentorial
25%
Radiologists
25%
Severity Level
25%
Lung Area
25%
Ground-glass Opacity
25%
Medicine and Dentistry
Radiation Exposure
50%
Cataract
50%
Interventional Cardiology
50%
Tocilizumab
50%
Ionizing Radiation
50%
Cytokine Storm
50%
Chest Radiograph
50%
Coronavirinae
50%
COVID-19
50%
Diagnostic Accuracy
50%
Dacryocystography
50%
Nasolacrimal Duct Obstruction
50%
Diseases
50%
Nuclear Medicine
50%
Radiation Protection
25%
Interleukin 6
25%
Obstruction
25%
General Radiography
25%
Interventional Radiology
25%
Mammography
25%
Thorax Radiography
20%
Lung
20%
Prevalence
18%
Multiple Organ Dysfunction Syndrome
16%
Acute Respiratory Distress Syndrome
16%
Receptor
16%
Pediatrics Patient
12%
Radiology
12%
Radiodiagnosis
12%
Scoring System
10%
Low and Middle Income Countries
10%
Infection
10%
Cross Sectional Study
10%
COVID-19 Diagnosis
10%
Hyperferritinemia
8%
Randomized Controlled Trial
8%
Monoclonal Antibody
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Nasal Cavity
8%
Side Effect
8%
Outpatient
8%
Epiphora
8%
Adverse Effect
8%
Odds Ratio
6%
